UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000016624 |
|---|---|
| Receipt number | R000019304 |
| Scientific Title | Phase II study of gemcitabine plus nab-Pacletaxel as second-line therapy after FOLFIRINOX for advanced pancreatic cancer |
| Date of disclosure of the study information | 2015/02/25 |
| Last modified on | 2022/09/01 12:24:23 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/02/25 06:40:11 | ||
| 2 | Update | 2016/08/27 16:49:46 | Name of primary person or sponsor Organization |
|
| 3 | Update | 2022/09/01 12:24:23 | Recruitment status Date of IRB |
